Seer (SEER) to Release Quarterly Earnings on Thursday

Seer (NASDAQ:SEER) will likely be announcing its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of ($0.32) per share and revenue of $4.60 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 4:30 PM ET.

Seer Price Performance

Shares of SEER opened at $2.02 on Thursday. The firm has a market capitalization of $112.70 million, a price-to-earnings ratio of -1.49 and a beta of 1.63. Seer has a 1-year low of $1.62 and a 1-year high of $2.41. The company has a 50-day moving average of $1.87 and a 200 day moving average of $2.02.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. grew its stake in shares of Seer by 51.6% during the first quarter. Goldman Sachs Group Inc. now owns 170,897 shares of the company’s stock worth $289,000 after acquiring an additional 58,173 shares during the last quarter. Jane Street Group LLC boosted its stake in Seer by 33.3% in the 1st quarter. Jane Street Group LLC now owns 254,174 shares of the company’s stock worth $430,000 after purchasing an additional 63,432 shares in the last quarter. Geode Capital Management LLC grew its position in Seer by 16.5% during the 2nd quarter. Geode Capital Management LLC now owns 509,727 shares of the company’s stock worth $1,091,000 after purchasing an additional 72,265 shares during the last quarter. XTX Topco Ltd acquired a new position in Seer during the 2nd quarter valued at approximately $172,000. Finally, Occudo Quantitative Strategies LP acquired a new position in Seer during the 2nd quarter valued at approximately $25,000. Hedge funds and other institutional investors own 75.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on SEER shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Seer in a report on Thursday, January 22nd. Wall Street Zen upgraded Seer to a “hold” rating in a report on Saturday, December 13th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Seer has an average rating of “Sell”.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.